UIM
ABMD

USS Investment Management’s Abiomed Inc ABMD Stock Holding History

USS Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,129
Closed -$3.23M – 608
2022
Q3 		$3.23M Buy
13,129
+57
+0.4% +$15.4K 0.05% 405
2022
Q2 		$3.24M Sell
13,072
-671
-5% -$181K 0.03% 470
2022
Q1 		$4.55M Buy
13,743
+3,754
+38% +$1.16M 0.04% 464
2021
Q4 		$3.59M Hold
9,989
– – 0.03% 529
2021
Q3 		$3.25M Buy
9,989
+3,959
+66% +$1.34M 0.03% 534
2021
Q2 		$1.88M Hold
6,030
– – 0.01% 442
2021
Q1 		$1.92M Hold
6,030
– – 0.02% 416
2020
Q4 		$1.96M Hold
6,030
– – 0.02% 387
2020
Q3 		$1.67M Hold
6,030
– – 0.02% 398
2020
Q2 		$1.46M Buy
6,030
+1,523
+34% +$306K 0.02% 417
2020
Q1 		$653K Buy
+4,507
New +$748K 0.01% 284

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

USS Investment Management's ABMD Position: Q4 2022 in Review

USS Investment Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 13,129 shares — an estimated $3.23M sold.

USS Investment Management first reported a position in ABMD in Q1 2020 and held it in 11 quarters. The position peaked at $4.55M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • USS Investment Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • USS Investment Management sold 13,129 Abiomed Inc shares in Q4 2022, an estimated $3.23M.
  • USS Investment Management first reported a position in Abiomed Inc in Q1 2020 and held it in 11 quarters.
  • USS Investment Management's Abiomed Inc position peaked at $4.55M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on USS Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.